Praxis Precision Medicines, Inc. (PRAX)
NASDAQ: PRAX · Real-Time Price · USD
310.82
-5.32 (-1.68%)
Apr 13, 2026, 8:13 AM EDT - Market open
PRAX Market Cap
PRAX has a market cap or net worth of $8.66 billion as of April 13, 2026. Its market cap has increased by 1,024.17% in one year.
Market Cap
8.66B
Enterprise Value
7.88B
1-Year Change
1,024.17%
Ranking
Category
Stock Price
$310.82
Market Cap Chart
Since the IPO on October 16, 2020, PRAX's market cap has increased from $698.02M to $8.66B, an increase of 1,140.15%. That is a compound annual growth rate of 58.26%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 10, 2026 | 8.80B | 19.46% |
| Dec 31, 2025 | 7.37B | 397.55% |
| Dec 31, 2024 | 1.48B | 675.84% |
| Dec 29, 2023 | 190.94M | 70.27% |
| Dec 30, 2022 | 112.14M | -87.31% |
| Dec 31, 2021 | 883.49M | -58.02% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 16, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BioMarin Pharmaceutical | 10.83B |
| ABIVAX Société Anonyme | 9.77B |
| Arrowhead Pharmaceuticals | 9.27B |
| Axsome Therapeutics | 9.15B |
| Vaxcyte | 8.88B |
| Bio-Techne | 8.69B |
| Nuvalent | 8.22B |
| Cytokinetics | 7.96B |